Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep1395 | Thyroid (non-cancer) | ECE2017

Stimulated calcitonin levels as a predictor of medullary thyroid cancer

Alexandra Gheorghiu Cristina , Corneci Cristina , Jercalau Simona , Dobrescu Ruxandra , Mihai Daniel , Badiu Corin

Abstract: Medullary thyroid cancer (MTC) is a highly aggressive neuroendocrine tumour originating in the thyroid parafollicular cells. Calcitonin measurement and RET gene ascertainment have been used as markers for early diagnosis of MTC. Since pentagastrin is not available, calcium stimulation test helps to preclude ‘gray zone’ values of basal calcitonin, diagnose minimal residual disease and help the early diagnosis of C cell hyperplasia.Aim:...

ea0035p86 | Bone and Osteoporosis | ECE2014

The 10-year absolute fracture risk and central DXA correlations in 505 Romanian menopausal women

Carsote Mara , Radoi Valentin , Mihai Alexandra , Geleriu Andreea , Baciu Ionela , Capatana Cristina , Paun Diana , Poiana Catalina

Introduction: The new tool FRAX indicated risk of fracture, using or not DXA which is the golden standard for osteoporosis diagnosis.Aim: We analyzed the lumbar DXA correlations with 10-year fragility fracture risk probability.Material and method: A cross sectional study in postmenopausal women was designed. They were osteoporosis free at baseline; none of them has previously been treated for osteoporosis. The anamnesis, the anthro...

ea0035p612 | Endocrine tumours and neoplasia | ECE2014

Metabolic and cardiovascular complications in patients with adrenal incidentalomas

Gheorghiu Monica Livia , Voicu Alina , Caragheorgheopol Andra , Coculescu Mihai , Poiana Catalina

Introduction: We evaluated the prevalence of metabolic and cardiovascular complications in a Romanian population with adrenal incidentalomas in comparison with an age-matched control group, evaluated in our clinic.Patients and methods: After excluding patients with overt functioning adrenal tumors, subclinical pheochromocytomas, malignant tumors, myelolipomas, data were retrieved from the files of 190 patients with adrenal incidentalomas ≥1 cm and ...

ea0035p891 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Pituitary non-secreting micro-incidentalomas and endocrine dysfunctions: a retrospective analysis in 236 Romanian patients

Carsote Mara , Mihai Alexandra , Geleriu Andreea , Dumitrascu Anda , Hortopan Dan , Petris Rodica , Paun Diana , Poiana Catalina

Introduction: The pituitary non-secreting microadenomas (or incidentalomas) are frequently diagnosed over the last decades thanks to imagery scan progresses and access. The gonadal dysfunction, as well as other pituitary deficiency is related to common genetic backup (+/− other pituitary dysfunctions) or may be incidental.Aim: We analyzed the endocrine profile in pituitary incidentalomas (microadenomas).Material and method: A...

ea0035p892 | Pituitary Clinical (<emphasis role="italic">Generously supported by IPSEN</emphasis>) | ECE2014

Pituitary incidentaloma: an age-related study in 266 Romanian patients

Poiana Catalina , Carsote Mara , Ene Cristina , Mihai Alexandra , Dumitrascu Anda , Dusceac Roxana , Niculescu Dan , Peretianu Dan

Introduction: The pituitary tumors which are considered pituitary incidentalomas are accidentally discovered at pituitary scan and they associate a lack of pituitary hyper-secretion. Opposite to what generally are considered for adrenal incidentalomas, the pituitary incidentalomas are more frequent with years of life.Aim: We analyzed the incidentaloma sizes related to decades of age.Material and method: This is a retrospective stud...

ea0070aep75 | Adrenal and Cardiovascular Endocrinology | ECE2020

Differential diagnosis of primary adrenal insufficiency in a young male with mental retardation and axonal sensorimotor polyneuropathy

Cristina Baleanu Maria , Galoiu Simona , Popa Lavinia , Margarit Emma , Constantin Marinescu Mihai , Caragheorgheopol Andra , Poiana Catalina

Introduction: Primary adrenal insufficiency (PAI) is a rare disease with a prevalence of 82–144 cases/milion. The etiology of PAI is represented primarily by autoimmune adrenalitis, followed by tuberculosis and less common by fungal infections, HIV, hemorrage in adrenal glands, certain drugs and by some genetic disorders such as Triple A syndrome (AAA), Adrenoleukodystrophy (ALD), congenital adrenal hypoplasia, congenital adrenal hyperplasia, etc.C...

ea0070aep538 | Endocrine-related Cancer | ECE2020

Functional and morphologic response to somatostatin analogues of a pancreatic gastrinoma with unusual presentation

Constantin Marinescu Mihai , Baciu Ionela , Pascu Polina , Rotarescu Alexandra , Cristina Baleanu Maria , Poiana Catalina

Introduction: Gastrinoma is rare gastrin-secreting neuroendocrine tumor (NET), usually located in the pancreas or duodenum. The most common presentations of gastrin secreting tumor is Zollinger-Ellison Syndrome (ZES). Only about 10% of patients have non demonstrable ulcer.Case presentation: A 67 years old female, with premature menopause, mild hypothyroidism with optimal replacement treatment, osteopenia and history of chronic gastritis, is admitted to o...

ea0070ep501 | Thyroid | ECE2020

Early diagnosis of acromegaly in chronic thyroiditis-case report

Stancu Ana-Maria , Gabriela Marin Alexandra , Beatrice Preda-Ivascu Monalisa , Mihai Daniel , Stancu Cristina , Badiu Corin

Introduction: Acromegaly is characterized by a pituitary adenoma with excess secretion of GH and IGF-1 hormones. More than 90% of the cases are diagnosed as macroadenomas, after 5 to 10 years of clinical manifestation.Case report: We present the case of a 49 years old man with minor thalassemia, hospitalized in endocrinology department for a routine check of chronic autoimmune thyroiditis. A careful anamnesis showed that in the last year the patient was ...

ea0031p259 | Pituitary | SFEBES2013

Short-term (3 months) compared to long-term response to somatostatin analogues in acromegaly

Gheorghiu Monica Livia , Vintila Madalina , Purice Mariana , Poiana Catalina , Coculescu Mihai

Objective: To evaluate whether serum GH and IGF1 levels achieved after 3 months treatment with somatostatin analogues (SSA) are concordant with the efficacy of SSA after longer treatment with the same dose.Patients and methods: From 71 patients with acromegaly treated with SSA in our clinic, in 38 of them (28 women, 10 men, aged 22–62 years) data on serum GH and IGF1 were available at baseline, after 3 months and at the last evaluation on the same S...

ea0022p455 | Endocrine tumours &amp; neoplasia (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Clinical characteristics of incidentally discovered phaeochromocytomas

Gheorghiu Monica Livia , Baciu Ionela , Mangalagiu Mara , Banaru Ana , Poiana Catalina , Badiu Corin , Coculescu Mihai

Introduction: Phaeochromocytomas (PHEO) are tumours of the chromaffin cells and are usually detected due to the typical symptom triad including headache, palpitations and sweating associated with persistent and/or paroxysmal blood hypertension. An increasing proportion of PHEO is incidentally discovered upon abdominal imaging.Objective: To analyse the clinical characteristics of the incidentally discovered phaeochromocytomas.Method...